OPKO Health, Inc. (TLV:OPK)
440.00
+9.30 (2.16%)
Dec 4, 2025, 5:24 PM IDT
OPKO Health Revenue
OPKO Health had revenue of $151.67M USD in the quarter ending September 30, 2025, a decrease of -12.65%. This brings the company's revenue in the last twelve months to $642.07M, down -9.75% year-over-year. In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%.
Revenue (ttm)
$642.07M
Revenue Growth
-9.75%
P/S Ratio
1.57
Revenue / Employee
$214.24K
Employees
2,997
Market Cap
3.33B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
| Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
| Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
| Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
| Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
| SofWave Medical | 255.13M |
| Ilex Medical | 915.05M |
| Novolog (Pharm-Up 1966) | 1.97B |
OPKO Health News
- 14 days ago - Friday 11/21 Insider Buying Report: GLOO, OPK - Nasdaq
- 16 days ago - JP Morgan Initiates Coverage on OPKO Health with Neutral Rating | OPK Stock News - GuruFocus
- 16 days ago - OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - OPKO Health Inc (OPK) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Performance - GuruFocus
- 5 weeks ago - Q3 2025 OPKO Health Inc Earnings Call Transcript - GuruFocus
- 5 weeks ago - OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands - Nasdaq
- 5 weeks ago - OPK: Barrington Research Maintains Outperform Rating with $2.25 Price Target | OPK Stock News - GuruFocus
- 5 weeks ago - Decoding OPKO Health Inc (OPK): A Strategic SWOT Insight - GuruFocus